FSD Pharma Inc.

HUGE | News | $0.4634 -5.24% -5.52% 280K

(0.0% 1d) (-24.3% 1m) (-67.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 18,578,099
http://www.fsdpharma.com
Sec Filling | Patents | 23 employees

(CA) FSD Pharma, Inc. is a specialty biotech pharmaceutical research and development company. It focuses on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The company was founded by Thomas Fairfull, Zeeshan Saeed and Anthony J. Durkacz in 1994 and is headquartered in Cobourg, Canada.

skin autoimmunity endocannabinoid nervous system

add to watch list Paper trade email alert is off

Croda International Plc/ADR

COIHF | $61.01 43.36% 430

Process Industries

(0.0% 1d) (-1.0% 1m) (-29.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-52.43% volume)
Earnings Calendar:
Market Cap: $ 8,519,158,316
http://croda.com
Sec Filling | Patents | n/a employees

(GB) Croda International Plc engages in the manufacture and sale of specialty chemicals. It operates through the following business segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. The Personal Care segment offers a range of speciality sustainable skin care, hair care, and solar protection ingredients. The Life Sciences segment includes crop care and healthcare speciality ingredients. The Performance Technologies segment supports the circular economy and durable material design, enabling the growth of clean energy, and helping to further reduce negative environmental impact. The Industrial Chemicals segment focuses on its biosurfactant plant at Atlas Point in North America. The company was founded by George Crowe and Dawe on May 25, 1925 and is headquartered in Goole, the United Kingdom.

education skin energy solar

add to watch list Paper trade email alert is off